NCT02559934View on ClinicalTrials.gov

Multiple-dose Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

January 31, 2019

Study Completion Date

May 31, 2019

Conditions
Actinic Keratosis
Interventions
DRUG

SR-T100 Gel

0.3-0.5 g topical SR-T100 gel (containing 2.3% solamargine in Solanum undatum plant extract)

Trial Locations (1)

701

National Cheng Kung University Hospital, Tainan City

All Listed Sponsors
lead

G&E Herbal Biotechnology Co., LTD

INDUSTRY

NCT02559934 - Multiple-dose Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis | Biotech Hunter | Biotech Hunter